Lotte E. Elshof

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ – The LORD study

Lotte E. Elshof, Konstantinos Tryfonidis, Leen Slaets et al. · European Journal of Cancer · 2015 · 369 citations · Full text

Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ

Lotte E. Elshof, Marjanka K. Schmidt, Emiel J. Rutgers et al. · Annals of Surgery · 2017 · 76 citations · Full text

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women

Lotte E. Elshof, Michael Schaapveld, Marjanka K. Schmidt et al. · Breast Cancer Research and Treatment · 2016 · 65 citations · Full text

Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma <i>In Situ</i> —A Nested Case–Control Study

Lindy L. Visser, Lotte E. Elshof, Michael Schaapveld et al. · Clinical Cancer Research · 2018 · 43 citations · Full text

A practical approach to manage additional lesions at preoperative breast MRI in patients eligible for breast conserving therapy: results

Lotte E. Elshof, Emiel J. Rutgers, Eline E. Deurloo et al. · Breast Cancer Research and Treatment · 2010 · 41 citations · Full text